Oncology

The complexities of cancer and the ever-changing medication regimens employed in its treatment call for the specialized competencies of oncology-focused pharmacies. High-touch care and oncology expertise can improve outcomes.

Oncology nurses help improve patient outcomes through their dedication and expertise.

Research suggests salaried physicians practice in the same manner as those reimbursed by fee-for-service methodology.

Primary androgen-deprivation therapy appears not to be an effective treatment for men with clinically localized prostate cancer.

Service to dispense oral oncolytics to patients shows positive results, doctors say.

An increase in the number of available anti-cancer drugs will also help lead to more people surviving the disease than ever before.

Using a very high sensitivity assay analyzing changes in levels of MPO and troponin I before, and 3 months after starting a chemotherapy regimen, investigators were able to predict 46.5% of cases of chemotherapy-associated cardiotoxicity before they occurred.

Deaths from chronic hepatitis C virus infection in the United States are grossly underreported, the results of a new study indicate.

Women who take aspirin regularly may be at a reduced risk for ovarian cancer, the results of a new meta-analysis suggest.

Rounding doses of ipilimumab to the nearest 50 mg resulted in significant cost savings for institutions, a new study found.

Scientists are using monoclonal antibodies to help the body fight off tumors in the same way that the body fights off infections. Monoclonal antibodies that target the interaction of programmed-death receptor-1 (PD-1) on T cells and its ligand (PD-L1) on tumor cells. Merck's MK-3475 prevents the interaction of PD-1 and PD-L1, thereby inhibiting a mechanism by which some tumors avoid immune detection.

Men who continue to smoke after being diagnosed with cancer are significantly more likely to die than those who quit, according to a recent study conducted in China.

The American Journal of Managed Care presents exclusive videos from the 2013 Patient-Centered Oncology Care: Real-World Perspectives conference.

Investigators strengthened the results of a 2012 trial with a long-term follow-up of an important phase III trial evaluating a bortezomib-based regimen versus a vincristine-based regimen.

Patients who received lower levels of opioid painkillers due to use of neuraxial analgesia along with general anesthesia had lower levels of systematic progression and overall death than those who received general anesthesia alone.

The latest lung cancer screening recommendations suggest that heavy smokers be screened for the disease annually once they reach 55 years of age.

The vasopressin-2 receptor antagonist tolvaptan was effective at treating hyponatremia in 10 patients with small cell lung cancer, according to a prospective case series report.

November, or Movember, has become a month in which normally clean-shaven men grow mustaches to help raise awareness about men's health and the need to get screened for conditions such as prostate and testicular cancer.

Women diagnosed with ductal carcinoma in situ, a noninvasive breast malignancy, may be more likely to choose surgery over noninvasive options when the condition is described using the word "cancer."

New research suggests that yoga may help cancer survivors sleep more and sleep better after treatment.

Risk of death from prostate cancer was reduced for patients who started taking statins after being diagnosed with the disease and was reduced even more for those who started taking statins before being diagnosed.

Those concerned about different types of cancer should band together to support research into prevention, detection, and cure-and to counter the exorbitant expense of treatment.

A study including 10 million patients covered by 11 health plans suggested that insurance claims could be used to estimate the number of early-stage breast cancer cases as well as the demand for anti-HER2 drugs.

Gilotrif (afatinib) is a first-line oral treatment for certain non-small cell lung cancers.